Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain

European Journal of Pharmacology

Volumn 295, Issue 2-3, 1996, Pages 189-197

  Moret, Chantal ^a   Briley, Mike ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); 5 HT uptake inhibitor; Antidepressant; Hypothalamus; Microdialysis; Rat

Indexed keywords

1 (1 NAPHTHYL)PIPERAZINE; 5 HYDROXYINDOLEACETIC ACID; AUTORECEPTOR; CITALOPRAM; METITEPINE; SEROTONIN; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TETRODOTOXIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG POTENTIATION; HYPOTHALAMUS; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC TRANSMISSION;

EID: 0030067409     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00646-X     Document Type: Article

References (27)

1. Bel, N. and F. Artigas, 1993, Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei, Synapse 15, 243.
2. 1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats. Psychopharmacology 117, 358.
3. Briley, M. and C. Moret, 1993, Neurobiological mechanisms involved in antidepressant therapies, Clin. Neuropharmacol. 16, 387.
4. Carboni, E. and G. Di Chiara, 1989, Serotonin release estimated by transcortical dialysis in freely-moving rats, Neuroscience 32, 637.
5. Chaput, Y., C. De Montigny and P. Blier, 1986, Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain, Naunyn-Schmied. Arch. Pharmacol. 333, 342.
6. Chaput, Y., P. Blier and C. De Montigny, 1988, Acute and long-term effects of antidepressant serotonin (5-HT) reuptake blockers on the efficacy of 5-HT neurotransmission: electrophysiological studies in the rat central nervous system, Adv. Biol. Psychiat. 17, 1.
7. Feighner, J.P. and W.F. Boyer, 1991, Selective Serotonin Reuptake Inhibitors (Wiley, Chichester).
8. Fuller, R.W., 1993, Do reuptake inhibitors increase extracellular 5-HT in all terminal regions? Microdialysis studies with 5-HT reuptake inhibitors, Trends Pharmacol. Sci 14, 397.
9. Galzin, A.-M., C. Morel, B. Verzier and S.Z. Langer, 1985, Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus, J. Pharmacol. Exp. Ther. 235, 200.
10. 1A agonists with potential anxiolytic properties, J. Pharmacol. Exp. Ther. 246, 745.
11. 1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis, Neuropharmacology 33, 331.
12. 1A agonist 8-OH-DPAT preferentially activates cell body 5-HT autoreceptors in rat brain in vivo, Naunyn-Schmied. Arch. Pharmacol. 338, 463.
13. Hjorth, S., C.S. Suchowski and M.P. Galloway, 1995, Evidence for 5-HT autoreceptor-mediated, nerve impulse-independent, control of 5-HT synthesis in the rat brain, Synapse 19, 170,
14. Hyttel, J., K. Fredricson Overo and J. Arnt, 1984, Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT uptake inhibitor, citalopram, Psychopharmacology 83, 20.
15. 1A receptors, Eur. J. Pharmacol. 260, 243.
16. Johnson, A.M., 1992, Paroxetine - a pharmacological review, Int. Clin. Psychopharmacol. 6, 15.
17. 1A receptors in the rat brain, Naunyn-Schmied. Arch. Pharmacol. 347, 453.
18. Lawrence, A.J. and C.A. Marsden, 1992, Terminal autoreceptor control of 5-hydroxytryptamine release as measured by in vivo microdialysis in the conscious guinea-pig, J. Neurochem. 58, 142.
19. Matos, F.F., H. Rollema and A.I. Basbaum, 1990, Characterization of monoamine release in the lateral hypothalamus of awake, freely moving rats using in vivo microdialysis, Brain Res. 528, 39.
20. Moret, C. and M. Briley, 1990, Serotonin autoreceptor subsensitivity and antidepressant activity, Eur. J. Pharmacol. 180, 351.
21. Moret, C. and M. Briley, 1993, The unique effect of methiothepin on the terminal serotonin autoreceptor in the rat hypothalamus could be an example of inverse agonism, J. Psychopharmacol. 7, 331.
22. Moret, C. and M. Briley, 1995, In vitro and in vivo activity of 1-(1-naphthyl)piperazine at terminal 5-HT autoreceptors in guinea-pig brain, Naunyn-Schmied. Arch. Pharmacol. 351, 377.
23. Moret, C., M. Charvéron, J.P.M. Finberg, J.P. Couzinier and M. Briley, 1985, Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug, Neuropharmacology 24, 1211.
24. Paxinos, G. and G. Watson, 1986, The Rat Brain in Stereotaxic Coordinates (Academic Press, Sydney).
25. Sleight, A.J., R.J. Smith, C.A. Marsden and M.G. Palfreyman, 1989. The effects of chronic treatment with amitriptyline and MDL 72394 on the control of 5-HT release in vivo, Neuropharmacology 28, 477.
26. 1B agonists, Synapse 1, 3.
27. 1Dα receptors: evidence for negative efficacy of 5-HT receptor antagonists, Br. J. Pharmacol. 114, 153P.